CDX2 and head and neck squamous cell carcinoma: Our in vitro and in vivo data consistently indicate that CDX2 induces the migration and infiltration of NK cells, increases the secretion of IFN‐γ and TNF‐α by NK cells, enhances NK cell toxicity against HNSCC, and suppresses the tumour growth in mice.